Financials
- Market Capitalization 20.94 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.05
ratio cours/chiffre d'affaires
-280.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4593 | CELU Celularity Inc. - Class A Common Stock | 0.76 USD | 0.00% | 0.00% | -5.00% | -68.60% | 22.00 M USD | ||
| 4604 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.69 USD | +2.28% | +0.37% | +16.96% | -14.33% | 21.50 M USD | ||
| 4611 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.32 USD | -3.33% | +0.87% | -7.57% | +146.81% | 19.98 M USD | ||
| 4620 | KALA KALA BIO, Inc. - Common Stock | 1.09 USD | 0.00% | -27.81% | -59.33% | -81.21% | 20.26 M USD |